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Objective: To explore the effect and speciﬁc mechanism of lung-tonifying and expec-
torant decoction on lung cancer rats with Qi deﬁciency and blood stasis, and aim to
provide a new idea on treating the disease with traditional Chinese medicine based on
syndrome differentiation.
Methods: A total of 60 C57BL/6J male rats were included in the study. The model of Qi
deﬁciency and blood stasis was established in 60 rats by using multiple-factor stimula-
tion. About 10 rats were randomly taken to verify whether the model establishment was
successful and the rest of 50 rats were divided into 5 groups with 10 rats each: blank
control group, cisplatin group, low dose group, medium dose group and high dose group.
The blank control group was treated with normal saline, and cisplatin group was treated
with cisplatin while the other three groups were treated with lung-tonifying and expec-
torant decoction at different doses. The volume change in transplanted tumor, tumor
inhibition rate, apoptosis rate, and expression of Bcl-2, Bax, cleaved caspase-3 and
cleaved caspase-9 in 5 groups were compared.
Results: The rapidest growth rate of transplanted tumor volume was observed in blank
control group and the slowest in cisplatin group. The growth rate was gradually decreased
with the increasing dose of lung-tonifying and expectorant decoction, and the difference
in growth of tumor volume among groups was statistically signiﬁcant (P < 0.05). The
cisplatin group showed the highest tumor inhibition rate, with dose-dependent increase
(P < 0.05). The apoptosis rate in low dose group was higher than blank control group but
lower than high dose group (P < 0.05). The apoptosis rate in medium dose group was
signiﬁcantly higher than blank control group (P < 0.05). The apoptosis rate in high dose
group was signiﬁcantly higher than control group (P < 0.05). The positive expression
rates of Bcl-2 and Bax in all groups showed statistically signiﬁcant difference (P < 0.05),
while expression of cleaved caspase-3 and cleaved caspase-9 in 5 groups was signiﬁ-
cantly different, with dose-dependent increase (P < 0.05).
Conclusions: The lung-tonifying and expectorant decoction inhibits the proliferation of
tumor cells by inducing and activating the cell apoptosis in treatment of lung cancer with
Qi deﬁciency and blood stasis, probably with good clinical therapeutic effect.1. Introduction
Lung cancer is a kind of malignant tumor with the highest
morbidity and mortality in the world; based on the statistical data
from Worth Health Organization, the morbidity of lung cancer
tops the list and accounts for 12.6% of newly discovered cancerpatients and 17.8% of patients who are died of cancer [1]. In
recent years, the morbidity of lung cancer in China has been
increased year by year, with data showing that it increases at
the rate of 11% annually; many scholars predict that by 2025,
the newly increased lung cancer patients would probably reach
1 million and 900 thousand would die of lung cancer, and
China would become the kingdom of lung cancer in the world
[2]. By far, the etiology and pathogenesis of lung cancer still
remains unclear and many studies report that it may be closely
related to smoking, air and environmental pollution,
occupational exposure, genetic and individual factors, etc. The
major treatments for lung cancer are surgery, radiotherapy,open access article under the CC BY-NC-ND
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achieve certain degree of efﬁcacy but fail to meet the patients'
expectations and a deeper research is required. Researchers
claimed that the basic principles for lung cancer treatment,
‘individualized treatment, chemotherapy by stage, local-whole
balance, survival rate-survival quality balance, cost-effect bal-
ance, Chinese-western balance, constant veriﬁcation’, carried
considerably guiding signiﬁcance in clinical treatment [3].
Lung cancer belongs to the category of ‘lung block, rushing
respiration, breath with cough, lung cough, lung distension’ in
the theory of traditional Chinese medicine. Lung is a delicate
organ, susceptible to invasion of harmful substance which would
cause disorder in lung, stasis in Qi and blood, obstruction in
veins and arteries, coexistence of toxin and blood stasis, and the
lump would be formed as time passes. Spleen is the organ
producing phlegm while lung is the one reserving phlegm. If the
transportation and transformation of spleen fail, the essence of
water and food cannot be transported and transformed so that the
damp can be easily gathered, and phlegm is produced and re-
mains in lung. The clinical symptoms for patients at early stage
are mild and both lung and spleen are hurt. As the condition
progresses, Qi-stagnation and blood stasis would occur, phlegm
would be produced, heat-transmission would develop after long-
time stasis, and ﬂuids would be consumed; deﬁciency syndrome
is more common. A number of doctors believe that the
morbidity of lung cancer is closely related to Qi deﬁciency as
well as invasion of harmful substance, and meanwhile the
weakness of body is the internal cause of viscera imbalance
while the invasion of harmful substance is the external cause. It
is believed that the basic principles of “differentiating symptoms
and disease, strengthening the Qi while eliminating the patho-
genic factors, concentrating in local and whole, regulating yin-
yang balance” in treatment can not only effectively kill and
inhibit lung cancer cells, and control the condition, but also can
regulate the body, improve the immunologic function and
further improve the overall therapeutic effect. Researchers in one
study analyzed 108 cases of advanced non-small cell lung cancer
and found out that about 60.2% of patients were Qi deﬁciency
and blood-stasis syndrome and thus, supplementing Qi and
activating blood circulation, dissipating phlegm and resolving
masses were the major way for treatment [4]. The present study
takes lung cancer rats with Qi deﬁciency and blood stasis as
objects, to preliminarily explore the molecule mechanism of
cell apoptosis in treating lung cancer with Qi deﬁciency and
blood stasis by using lung-tonifying and expectorant decoction
at different concentrations and to provide new ideas and refer-
ence base for future clinical treatment.
2. Materials and methods
2.1. Experimental materials
2.1.1. Animal
C57BL/6J male rats free from speciﬁc pathogen, weighed
20–22 g, were purchased from Animal Experiment Center of
School of Medicine, Wuhan University, with Catalog No.
00015614, and were raised at room temperature.
2.1.2. Equipments and instruments
The Lewis lung cancer cell line was purchased from Shanghai
Cell Institutes, Chinese Academy ofMedical Sciences. The Formavertical ultra-low temperature refrigerator was purchased from
Thermo company.Ⅸ51 inverted microscope was purchased from
OLYMPUS, Japan. CO2 constant temperature incubator was pur-
chased from Thermo Company. Microscopic image acquisition
system was purchased from OLYMPUS, Japan (Ⅸ71 + cryogenic
camera). Biological safety cabinet was purchased from Thermo
Company. Low speed desktop centrifuge (TDZ5-WS) was pur-
chased fromWuhanFaceTradeLimitedCompany.Electro thermal
and thermostatic water tank was purchased from Wuhan Ideal
Scientiﬁc Equipment Co., LTD. Minipump was purchased from
Qilinbeier Company (GL-802B). Precision electronic balance was
purchased from Precisa, Switzerland (ES8200C 10 mg–8000 g).
Image analysis software used in the study was Image-Pro Plus5.0.
2.1.3. Medicines and chemical reagents
The 10% fetal calf serum (NQBB import original), dulbecco's
modiﬁed eagle medium, trypsin (0.25% pancreatin and 0.02%
ethylene diamine tetraacetic acid, biological reagent), and sterile
Hanks buffer solution were from Wuhan Jieyangsheng Science
and Technology Ltd. The components of lung-tonifying and
expectorant decoction were: Codonopsis pilosula 20 g, Astra-
galus membranaceus 15 g, unprocessed rehmannia 15 g, aster
10 g, Ligusticum wallichii 10 g, red peony root 12 g, Salvia
miltiorrhizae 10 g, radix peucedani 10 g, almond 10 g, Curcuma
zedoaria 10 g, rhizoma sparganii 10 g, Sculellaria barbata 10 g,
Oldenlandia diffusa 15 g, carapax trionycis 10 g and liquorice
6 g. Cisplatin injection was from Hospira Australia Pty Ltd.,
with Catalog No. H20090521 (50 mL:50 mg).
2.2. Establishment of lung cancer models with Qi
deﬁciency and blood stasis
A total of 60 cleaning C57BL/6J male rats weighed 20–22 g,
with age of 5 wk, were included in the study and raised in animal
room with constant temperature and humidity. Food and water
were autoclaved.
The 60 rats were made into models of Qi deﬁciency and
blood stasis by using multiple-factor stimulation according to [5].
The performance and symptoms of rats were observed. About
6 wk after the modeling operation, 10 rats were randomly
taken out to verify whether the model establishment was
successful, by determining the blood rheology of eyeball blood.
2.3. Grouping and administration
The Lewis lung cancer cell line at logarithmic phase was
taken to digest, centrifuge, count and resuspend to make a sus-
pension at the concentration of 1.0 × 107/mL. About 0.2 mL of
suspension was inoculated to the right axilla of rats subcutane-
ously, after which the rest 50 rats were divided into 5 groups
with 10 in each. The blank control group was treated with
normal saline and raised normally, while cisplatin group was
treated with intraperitoneal injection of cisplatin 1 mg/kg per day
For the other three groups, the effective constituents in lung-
tonifying and expectorant decoction were extracted through
decocting method; and low dose group, medium dose group and
high dose group were divided according to the 5, 10, 20 times
human equivalent dose. For low dose group, 0.7 g/kg lung-
tonifying and expectorant decoction was given per day, and
1.4 g/kg for medium dose group per day while 2.8 g/kg for high
dose group per day. The dosage was 0.5 mL for each rat once a
Table 2
Index related to tumor in Lewis lung cancer rats (mean ± SD).
Groups n Tumor
weight (g)
Tumor weight
index
Tumor
inhibition
rate
Blank control group 10 3.64 ± 0.75 0.154 ± 0.115 –
Cisplatin group 10 1.48 ± 0.35 0.068 ± 0.052 59.240
Low dose group 10 2.78 ± 0.46 0.115 ± 0.085 24.180
Medium dose group 10 2.42 ± 0.55 0.102 ± 0.064 28.540
High dose group 10 2.16 ± 0.45 0.088 ± 0.034 38.250
t – 22.658 13.584 4.352
P – 0.000 0.009 0.012
Feng Yuan et al./Asian Paciﬁc Journal of Tropical Medicine 2015; 8(11): 983–988 985day. The rats in experiment group were raised by giving a
gavage of isopyknic normal saline and cisplatin group was given
daily intraperitoneal injection of cisplatin at the dose of 1 mg/kg.
2.4. Indexes observation
The general condition and mental state of rats were observed
every 3 d, and the size of tumor was measured with vernier
caliper. According to the formula V = ab2/2, the volume of tu-
mor was calculated (a is the shortest diameter of tumor, b is the
longest diameter), and the tumor growth curve was drawn.
About 3 wk after continuous medication, the animals were
sacriﬁced and the tumors without subsidiary tissue were taken
for measurement of weight. The tumor weight index and tumor
inhibition rate were calculated by using the following formula
respectively: tumor weight index = weight of tumor/weight of
body; tumor inhibition rate = (1 − average weight of tumor in
experiment group/average weight of tumor in control
group) × 100.00%. The tumor apoptosis index was determined
by using terminal deoxynucleotidyl transferase (TdT)-mediated
dUTP nick-end labeling method [6], and expression of Bcl-2,
Bax, cleaved caspase-3 and cleaved caspase-9 in apoptosis
pathway was determined by using western blot [7].
Interpretation of results: when positive signal was located in
the karyon and the color varied from light yellow to brown along
with the levels of apoptosis, the criterion for apoptotic cells
assessment were: (1) single and scattered distribution; (2) no
inﬂammatory response all around; (3) apoptotic nuclei seen with
karyorrhexis, concentrated chromatin adhesion or pyknosis. If
no apoptosis was seen in positive cells, but they showed single
distribution and dramatically different stain intensity, they can
be identiﬁed as apoptotic cells. The apoptotic index was calcu-
lated in the view of 2000 cells at high magniﬁcation of 10 × 40.
2.5. Statistical analysis
The data were input to SPSS18.0 software for processing.
The measurement data were expressed as mean ± SD. t test was
performed for the comparison between groups and intra-group
comparison. The enumeration data were expressed as percent-
age and c2 was performed. Results with P < 0.05 were
considered to be statistically signiﬁcantly different.
3. Results
3.1. Effect of lung-tonifying and expectorant decoction
on tumor volume in Lewis lung cancer rats
During the 3-week continuous medication, no rats were dead
in all groups. The highest growth rate of volume was observed inTable 1
Change of tumor volume in Lewis lung cancer rats (mean ± SD, mm3).
Time
(d)
Blank control
group
Cisplatin
group
Low dose
group
4 4.25 ± 0.32 3.28 ± 0.52 4.12 ± 0.46
7 62.58 ± 4.85 41.72 ± 5.96 52.54 ± 5.36
10 148.36 ± 11.48 92.54 ± 20.45 125.42 ± 15.74
13 532.54 ± 35.56 253.46 ± 20.32 452.68 ± 41.18
16 1687.52 ± 85.36 678.58 ± 105.24 1208.52 ± 91.36
19 2250.25 ± 114.26 1014.56 ± 140.28 1745.28 ± 124.36
22 4102.58 ± 155.26 2154.48 ± 182.46 2936.52 ± 163.95blank control group while the lowest in cisplatin group. The
growth rate of tumor in experiment group was decreased along
with the increased dose of lung-tonifying and expectorant
decoction and the difference in volume growth in all groups at
different time was statistically signiﬁcant (P < 0.05) (Table 1).
3.2. Effect of lung-tonifying and expectorant decoction
on tumor inhibition rate in Lewis lung cancer rats
The heaviest tumor was observed in blank control group
while the lightest in cisplatin group, showing a decreasing trend
with the increased dose of lung-tonifying and expectorant
decoction (P < 0.05). The tumor weight index was the highest in
blank control group while the lowest in cisplatin group, showing
a decreasing trend with the increased dose of lung-tonifying and
expectorant decoction (P < 0.05). The highest tumor inhibition
rate was observed in cisplatin group, with the dose-dependent
increasing trend (P < 0.05) (Table 2).
3.3. Comparison of apoptosis rate of tumor cells and
protein expressions
The cell apoptosis rate in low dose group was higher than
that in blank control group but lower than that in cisplatin group,
with statistically signiﬁcant difference (P < 0.05). The apoptosis
rate in medium dose rate was signiﬁcantly higher than that in
blank control group (P < 0.05), but there was no statistically
signiﬁcant difference, compared with cisplatin group (P > 0.05).
The apoptosis rate in high dose group was signiﬁcantly higher
than in control group (P < 0.05). The difference of positive
expression rate of Bcl-2 and Bax in all groups was statistically
signiﬁcant (P < 0.05), and the difference in expression of
cleaved caspase-3 and cleaved caspase-9 in all groups was also
statistically signiﬁcant (P < 0.05), with dose-dependent trend
(P < 0.05) (Table 3).Medium dose
group
High dose
group
t P
3.78 ± 0.61 3.54 ± 0.48 6.766 0.000 2
50.74 ± 6.32 47.62 ± 5.88 18.029 0.000 0
113.28 ± 13.64 109.25 ± 12.68 18.818 0.000 0
424.58 ± 39.26 418.65 ± 36.58 82.819 0.000 0
1131.25 ± 88.25 1122.36 ± 89.65 151.203 0.000 0
1728.54 ± 127.38 1702.35 ± 108.25 127.187 0.000 0
2714.58 ± 158.42 2543.25 ± 156.38 202.168 0.000 0
Table 3
Comparison in cell apoptosis rate and expressions of apoptotic factors (mean ± SD).
Groups Cell apoptosis rate Bcl-2 (%) Bax (%) Cleaved caspase-3 Cleaved caspase-9
Blank control group 3.88 ± 2.35 21.14 ± 0.07 68.05 ± 0.08 0.002 ± 0.001 0.003 ± 0.002
Cisplatin group 10.98 ± 3.34 88.65 ± 14.36 10.26 ± 0.25 0.086 ± 0.026 0.085 ± 0.028
Low dose group 8.69 ± 1.36 72.68 ± 10.36 10.36 ± 1.08 0.014 ± 0.008 0.064 ± 0.022
Medium dose group 11.35 ± 2.08 85.26 ± 15.25 13.36 ± 1.28 0.098 ± 0.063 0.075 ± 0.054
High dose group 13.38 ± 1.45 96.15 ± 18.08 15.65 ± 1.98 0.145 ± 0.036 0.095 ± 0.026
t 26.443 51.843 63.277 30.010 13.469
P 0.000 0.000 0.000 0.000 0.000
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Traditional Chinese medicine plays an effective role in treat-
ing lung cancer by directly killing the tumor cells, inhibiting the
angiogenesis of tumor, regulating the organism's immunologic
function, reversing the multidrug resistance of tumor, inducing
the apoptosis of tumor cells, affecting the expression of onco-
gene, improving the microcirculation and hemorheology, and
inﬂuencing the proliferation cycle of tumor cells, etc. However,
there is no consolidated standard criterion in traditional Chinese
medicine for the differentiation and classiﬁcation, which are
mostly clinically done based on experience. In the traditional
Chinese medicine, it is held that lung cancer is a kind of disease
intermingled with both deﬁciency and excess, and that the deﬁ-
ciency of Qi and yin is the internal pathological basis while
deﬁciency, phlegm, stasis and toxin occur throughout the whole
pathogenetic process, which are also the necessary condition for
the morbidity of lung cancer. The treatment should be dependent
on the patient's clinical manifestation and therapeutic principles
should be formulated according to the differentiation and classi-
ﬁcation of symptoms and signs; clinically, treatments often start
from phlegm stagnation, spleen and lung, beneﬁting Qi and
activating blood circulation, and deﬁciency of yang [8]. The
present study aims to further explore the speciﬁc molecule
mechanism of cell apoptosis in clinical efﬁcacy of lung cancer
treatment, from the perspective of effect of lung-tonifying and
expectorant decoction on lung cancer, with reference of many
domestic reports and years' clinical experience.
Rat-derived and human-derived lung cancer cell lines are
usually used to establish the models of Qi deﬁciency and blood
stasis and they are often implanted to back side of axilla. In the
present study, Lewis lung cancer cell line was taken and
C57BL/6J male rats were chosen to avoid the immunoreaction
and rejection reaction caused by the implantation of human
lung cancer cell line A549. By choosing C57BL/6J male rats, it
can provide the most similar microcirculation to the one from
which tumor cells of lung cancer derives, maintain the original
biological characteristics of tumor cells, and more precisely
predict the therapeutic effect of lung-tonifying and expectorant
decoction on lung cancer treatment. Results showed the rap-
idest growth rate of tumor volume in blank control group and
the slowest in cisplatin group; it also showed that the growth
rate was gradually decreased with the increased dose of lung-
tonifying and expectorant decoction while the tumor inhibi-
tion rate increased with the dose-dependent trend (P < 0.05). In
addition, the results of tumor apoptosis index determined by
terminal deoxynucleotidyl transferase-mediated dUTP nick-
end labeling method showed that the application of lung-
tonifying and expectorant decoction can signiﬁcantly increasethe cell apoptosis rate, with dose-dependent trend, suggesting
that lung-tonifying and expectorant decoction can treat lung
cancer by activating the apoptosis system, and retarding the
proliferation and growth of lung cancer cells so that the ther-
apeutic effect of cisplatin can be achieved. However, in the
present study, the lung-tonifying and expectorant decoction
was not combined to use with cisplatin. Thus, the combination
of lung-tonifying and expectorant decoction and cisplatin may
need further research to explore the new ideas and methods to
clinically treat lung cancer and to further clinically improve the
therapeutic effect.
Many clinical researches conﬁrm that the incidence of tumor
is not simply caused by inﬁnite multiplication of cells and one
more important principle is the blocked apoptotic pathway and
lost apoptosis function [9]. Cell apoptosis, also called
programmed cell death, is a process that cells commit to
suicide actively and die, induced by signals inside and outside
the cells. The occurrence and development of cell apoptosis
can be divided into initial period, effective period, and
degradation period. After the integration of apoptosis signals
inside and outside the cells, the signaling protein in cytoplasm
would transmit the signals to the performer of apoptosis of
certain tissue, namely, caspase, and the activated caspase
would further degrade the speciﬁc substrate and lead to cell
apoptosis ﬁnally.
B cell lymphoma/leukemia-2 gene (Bcl-2 gene) is a kind of
the earliest known proto oncogene and the major modulator in
signal transduction of cell apoptosis, with the function to inhibit
the cell apoptosis [10]. At the present, at least 15 kinds of
homologous proteins of it are known and can be divided into
former apoptosis protein and inhibitor of apoptosis protein,
according to their structure and function. The inhibitor of
apoptosis protein, Bcl-2, can directly integrated with mito-
chondria and induce the release of cytochrome C. Bcl-x1 can
integrate with caspase-9 binding protein and activate the
caspase-9. Caspase-9 binding protein can inhibit the activation
of caspase-3. The former apoptosis protein Bax can directly
integrate with mitochondrial membrane to form transmembrane
channel for mitochondria and accelerate the release of cyto-
chrome C. Apoptosis protein Bid can be hydrolyzed by caspase-
8, and its hydrolysis product, carboxyl terminal fragment, can
trigger mitochondria to release cytochrome C. The nature of
genetic expression of Bcl-2 family is determined by the nature of
cells' receiving signal stimulus. The activation of inhibitor of
apoptosis protein is induced by cytokines while the expression
of former apoptosis protein is activated by DNA damage
transduced by P53 protein. The regulation of protein levels is the
reﬂection of Bcl-2 proteins’ function of regulating function and
the phosphorylation of apoptosis protein Bid can relieve its
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Bcl-2 gene mainly locates in the upstream of caspase-3 and
indirectly inhibits the activation of caspase-3 through factors in
the downstream so as to inhibit the cell apoptosis. Researchers
believed that Bcl-2 was the important inhibitory apoptotic gene,
whose overexpression can inhibit the cell apoptosis by pro-
longing the duration of tumor cells and inhibiting the release of
cytochrome C, Smac and apoptosis-inducing factors from
mitochondria by altering the permeability of mitochondria so as
to inhibit the integration of cytochrome C and Apaf-1, indirectly
inhibit the Pro-caspase-3 in the upstream and inhibit the cleaved
caspase-3 [12]. In another study, it was believed that Bcl-2 pro-
longed the life span of cells and increased the number of cells by
inhibiting cell apoptosis to hinder or delay the normal cell dif-
ferentiation, and thus increased the opportunity of genovariation
which contributed to the occurrence of tumor [13]. In another
study, adenovirus Bax gene was used to transfect human lung
cancer cell line and the activation as well as apoptosis of
caspase and the inhibition of cell proliferation, which can
inhibit the growth of tumor and up-regulate the expression of
Bax and induce apoptosis were observed [14].
Cysteinylaspartate-speciﬁc protease (caspase), is a sort of
zymogen, which has no active structure in the normal circum-
stances and can be activated into a group of enzymes with
protein solubility when induced by apoptosis signal. When cell
apoptosis happens, caspase is generally activated and thus
believed as the ﬁnal pathway for apoptosis. By far, caspase
family has got 14 members altogether, among which caspase-1
and caspase-3 are studied the most. Caspase family is the key
part in the process of cell apoptosis, whose activation and
abnormal expression can both lead to apoptosis, and hence, it is
called death protease that regulates cell apoptosis by interacting
with many protein factors [15]. Caspase regulates the cell
apoptosis through the interaction with cytochrome C, death
receptor, anti-apoptotic factors, apoptotic factors, and
apoptosis-inhibited factors, etc. A lot of researches afﬁrm that
the factor triggering the apoptosis in most cases, is ﬁnally related
to the signaling pathway mediated by caspase-3 that is closely
related to the occurrence and development of tumor. Generally,
caspase-3 exists in the cytoplasm as 23 ku Pro-caspase-3, and
when cells are activated and cleaved under the apoptosis signal,
cleaved caspase-3 is formed.
In many researches, it is veriﬁed that caspase-3 expression
in kinds of tumor cells is decreased [16], and it was reported
that caspase-3 expression in mucous epithelium of normal
bronchia, atypical hyperplasia, lung cancer, and metastatic
carcinoma of lymph node were gradually decreased and
believed that the under expression of caspase-3 may be closely
related to the occurrence and development of tumor [17].
Researchers in another study cultured human lung
carcinoma, squamous carcinoma, undifferentiated carcinoma,
and bronchoalveolar carcinoma in paclitaxel and found that
the apoptotic cells increased from 22% to 69%, and
meanwhile the activity of caspase-3 increased, suggesting
that paclitaxel can induce the apoptosis of human lung cancer
cells and is closely related to activity of caspase-3 [18]. It was
reported in another study that the abnormal activity of caspase-
3 in non-small cell lung cancer may be related to the defect in
the process in which activated caspase-3 in cytoplasm trans-
ferred to karyon [19].In conclusion, lung-tonifying and expectorant decoction may
carry good clinically therapeutic effect in the treatment for lung
cancer with Qi deﬁciency and blood stasis, by inducing and
activating the cell apoptosis to inhibit the proliferation of tumor
cells. However, further polycentric clinical experiments with
large sample should be required so as to conﬁrm the effective-
ness and security.
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